INTRODUCTION
Cystic fibrosis (CF; MIM no. 219700) is an autosomal recessive disease caused by mutations in CF transmembrane conductance regulator (CFTR). CFTR is expressed in the apical membrane of various epithelia and functions as a cyclic AMP-regulated anion channel. Loss-of-function due to severe mutations in both alleles causes dehydrated, thick and viscous luminal fluid in respiratory and gastrointestinal tract, pancreatic duct and vas deferens. CF typically involves chronic infection and progressive obstruction of the respiratory tract, pancreatic exocrine insufficiency and male infertility. CFTR mediates Cl À absorption by sweat duct, and the elevated sweat chloride is the gold standard for CF diagnosis.
CF is one of the most common hereditary diseases in Caucasians with an estimated incidence of 1 in 2500-3500 newborns. Diagnosis of CF can be made if the sweat chloride value is Z60 mmol l À1 in individuals presenting one or more characteristic symptoms or a positive family history. 1 Individuals with sweat chloride values in the intermediate range should underdo analysis of CFTR mutations. 2 The American College of Medical Genetics recommends a screening panel of 23 types of CF-causing mutations, which detects 85-88% of CF alleles in Caucasians. 3, 4 However, there are considerable regional and ethnic variations in the spectrum of the CFTR mutations. 5 CF is very rare in Japan approximately three per million. 6, 7 Definite diagnosis of CF is often difficult for Japanese patients because (1) sweat Cl À test with pilocarpine iontophoresis is not readily available in Japan and (2) most of the CFTR mutations are of rare types. The whole coding regions (27 exons) of the CFTR gene are scanned by single-strand conformational polymorphism analysis and/or direct sequence, when CF is suspected in Japanese. 8 However, a recent national surveillance of CF in Japan revealed that the presence of mutations in a substantial number of highly suspected cases remained unsolved (Research Committee of Intractable Pancreatic Diseases, data not published).
More than 1800 different mutations have been reported to the Cystic Fibrosis Mutation Database (www.genet.sickkids.on.ca/cftr), which includes 39 different genomic rearrangements, such as large deletion. Intragenic rearrangements (large deletions and to lesser extent, insertions) account for 1-3% of the CFTR mutations in Caucasians. 4 Large deletions in heterozygosis escape detection by conventional PCR-based techniques. In the present study, we detected a large heterozygous deletion spanning exons 16, 17a and 17b in a Japanese CF patient by analysis of CFTR transcripts extracted from nasal swab. The deletion was confirmed by the direct sequence of the junction fragment obtained by primer walking, which revealed the mutation c.2908 þ 1085_3367 þ 260del7201. The deletion was previously reported from a French CF patient and his healthy mother, who came from South Korea. 9 Analysis of the CFTR transcripts is also useful to detect splicing defects and reduced mRNA expression. More than 15% of diseaseassociated CFTR mutations modulate pre-mRNA splicing. 10 In the present study, we have identified a novel splicing defect in the CFTR transcript from the allele not lacking exons 16-17b . The deletion/ skipping of exon 1 by a splicing defect has not been reported in CF patients.
The screening of large genomic deletion and splicing defect by transcript analysis of nasal swab is recommended in the genetic analysis of CF in Japan and Asian countries, where common CFcausing mutations in Caucasians are rarely identified.
MATERIALS AND METHODS
The following study was approved by the Ethical Committee of Nagoya University Graduate School of Medicine.
Case report
A 1-year-old boy was admitted to hospital for the treatment of poor nutritional status. He is the first boy child of non-consanguineous Japanese parents. He had an operation for meconium ileus on the first day after birth, intrahepatic cholestasis and recurrent pneumonia. Mucoid strains of Pseudomonas aeruginosa were isolated from the sputa. Sudan stain of fecal fat was positive. Sweat Cl À concentration was elevated (122 mmol l À1 ) and he was diagnosed with CF.
Direct sequence of the CFTR gene
Genomic DNA was extracted from peripheral leukocytes. PCR was carried out using the primers shown in Table 1 . All 27 exons and their boundaries (100-300 bp including poly T and TG repeats in intron 8) and promoter region (up to 1028 bp upstream of the translation initiation codon of exon 1) were directly sequenced.
Cloning of the CFTR transcripts from nasal swab
Nasal epithelial cells were collected by gently brushing the inferior turbinates of both nostrils using a cotton swab. 11 The swab was immediately immersed in the Buffer RLT preservation solution (Qiagen, Hilden, Germany) and stored at À20 1C. Total RNA was extracted (750-3500 ng from one sample) and reverse transcribed to cDNA using two kinds of reverse transcriptase-primer; a random 6 mer and the gene-specific primer on exon 24 (5 0 -TCTGGCTTGCAAAACACAAG-3 0 ). The cDNA that was generated using the random 6 mer was amplified by PCR into 11 overlapping segments. Positions, primer sequences and predicted sizes of the segments are shown in Figure 1a and Table 2 . The cDNA generated using the gene-specific primer on exon 24 was subjected to long PCR analysis. Eight sets of long PCR (Figures 4a and e) were performed using the primers described in Table 3 . The PCR products were subject to agarose gel electrophoresis. The bands of predicted sizes were excised and purified.
The purified PCR products were cloned using the Mighty TA-cloning Kit (Takara Bio, Otsu, Japan). Colonies were screened for correct insertion of the plasmid by PCR and cultured for 14-16 h. The plasmid was extracted with the GeneElute Plasmid Miniprep kit (Sigma-Aldrich, St. Louis, MO, USA). The sequence reaction was carried out using the GenomeLab Dye Terminator Cycle Sequencing with Quick Start kit (Beckman Coulter, Fullerton, CA, USA). The reaction products were purified using the Centri-Sep spin columns (Applied Biosystems, Grand Island, NY, USA). Capillary electrophoresis and sequence was performed by CEQ 8000 system (Beckman Coutler).
Analysis of the genomic rearrangement of CFTR
Long PCR from exon 15 to exon 18 of the CFTR gene was performed using the forward primer on exon 15: 5 0 -CCAGCACCAGTTCGTATTATGTGTTTT-3 0 and the reverse primer on exon 18: 5 0 -AGCCCACTGCAATGTACTCATGA TATT-3 0 . The PCR protocol was polymerase activation at 94 1C for 5min, followed by 35 cycles of PCR with denaturation at 98 1C for 10 s, annealing and elongation at 68 1C for 11 min and final extension at 72 1C for 10 min. The PCR products were purified and cloned using the Mighty TA-cloning Kit.
The deletion breakpoint was identified by primer walking. 12 First set of primers were set on intron 15 and intron 17b. The positions of both primers were shifted towards the putative breakpoint in steps of 300-600 bp. Finally, we obtained the 470-480 bp PCR product, which spans intron 15-intron 17b and Defects in CFTR transcripts from nasal swab M Nakakuki et al harbors the breakpoint of the deleted sequence. The PCR product was sequenced directly. The established 'junction fragment' primers were used for the following study.
Amplification of the junction fragment
We developed a test to define the identified deletion by amplifying the junction fragment as shown in Figure 2b Quantitative fragment analysis by multiplex ligation-dependent probe amplification
Multiplex ligation-dependent probe amplification (MLPA), a quantitative PCR-based assay was performed to examine the presence of large deletion and duplication in the CFTR gene. 13 We used the SALSA P091-C1 CFTR MLPA kit (MRC Holland, Amsterdam, The Netherlands). The kit contains probes for each of the 27 exons of CFTR. Fragments were separated on CEQ-8000 capillary electrophoresis system (Beckmann Coulter) using the Beckmann D1-labeled CEQ size standard 600. P C P C P C P C P C 100bp M Defects in CFTR transcripts from nasal swab M Nakakuki et al
RESULTS

Direct
Analysis of the fragments of CFTR transcripts from nasal swab All the 11 pairs of primers ( Figure 1a ) successfully amplified the CFTR cDNA from the patient (P) and healthy control (C; Figure 1b ). The healthy control had a genotype of 11/12 TG repeats and 7/7 poly T in intron 8. PCR with the No. 4 pair of primers, which amplifies cDNA fragments spanning exons 7-10, produced the band of expected size (B560 bp) and the one of smaller size (B370 bp). The two bands were detected in both patient (P) and healthy control (C). Sequence of the purified products revealed that the two bands correspond to the normal fragment and the one lacking exon 9 (data not shown).
PCR with the No. 8 pair of primers, which amplifies cDNA fragments spanning exons 15-19, produced the band of expected size (B630 bp) in both patient (P) and healthy control (C). However, another band of smaller size (B170 bp) was detected in patient (P) in addition to the normal band. The PCR product was purified and cloned. Sequencing results revealed that the shorter fragment (173 bp) lacked exons 16, 17a and 17b (Figure 1c) .
Analysis of the genomic rearrangement of the CFTR gene Long PCR from exon 15 to exon 18 of CFTR detected approximately 4 kbp product from the patient genomic DNA and approximately 11 kbp product from the control genomic DNA. So-called primer walking was performed using the approximately 4 kbp product. We finally obtained the 470B480 bp product, which spans intron 15-intron 17b and harbors the breakpoint. Direct sequencing of the product revealed the deletion from nucleotide þ 1085 of intron 15 (the beginning of intron 15 defined as þ 1) to nucleotide þ 260 of intron 17b (the beginning of intron 17b defined as þ 1) with a loss of 7201 nucleotides, which was designated as c.2908 þ 1085_3367 þ 260 del7201 (Figure 2a) .
PCR with the pair of 'junction fragment' primers (A and C in Figure 2b to amplify the deleted allele) amplified the 471 bp product from the patient genomic DNA (lane 1 in Figure 2c ), but not from the control DNA (lane 2 in Figure 2c) . PCR with the pair of 'normal fragment' primers (A and B in Figure 2b to amplify the wild-type allele) amplified the 477 bp product from both the patient DNA (lane 3 in Figure 2c ) and the control DNA (lane 4 in Figure 2c ). The data indicated that the patient has the heterozygous deletion of Defects in CFTR transcripts from nasal swab M Nakakuki et al c.2908 þ 1085_3367 þ 260del7201. The junction fragment was not identified in Japanese healthy controls (n ¼ 48).
Quantitative fragment analysis of the CFTR gene by MLPA MLPA was performed to examine the presence of other large deletion or duplication in the CFTR gene. Figure 3a and b shows the original chromatograms of the patient (A) and the control (B). When the signals except for exons 16, 17a and 17b were normalized, the amount of the fragments corresponding to exon 16, 17a and 17b in the patient sample was reduced to 54, 50 and 54%, respectively, of the control sample. This finding confirmed the genomic deletion spanning exons 16, 17a and 17b in one allele. Genomic rearrangements were not detected in the other allele. However, the bands from the patient (P) sample were weak but of the same size. PCR of the fragments spanning exons 18-24 (No. 6 pair of primers) produced a band of the expected size in both patient (P) and healthy control (C). The density of the bands was similar. These data suggest that there is a deletion or skipping of exon 1 in the other allele. Defects in CFTR transcripts from nasal swab M Nakakuki et al
Mouchel et al. 14 reported alternative 5 0 upstream exons of CFTR (namely exons À1a and 1a), which were directly spliced to exon 2, excluding exon 1 from the transcript (Figure 4e ). To test this possibility, PCR was carried out by setting the forward primer on exon À1a and the reverse primer on exon 16 (No. 7 and 8 pairs of primers, Table 3 , Figure 4e ). Two weak bands were detected in the control (C), but not in the patient (P; Figure 4c ). Sequence of the purified product detected the splicing variants lacking exon 1 that exon À1a was spliced to exon 2 (data not shown). There was a 74 bp insertion (part of intron 2) between exons 2 and 3 in the longer fragment. The data suggest that the CFTR transcript from the other allele (without exons 16-17b deletion) of the patient is not the reported splicing variant.
DISCUSSION
In the present study, we detected a large heterozygous deletion in the CFTR gene in a Japanese CF patient. Cloning and sequence analysis of the CFTR transcripts from nasal swab revealed a heterozygous deletion spanning exons 16, 17a and 17b. None of the CF-causing mutations was detected by conventional PCR, and direct sequence of all 27 exons, their boundaries and promoter region. The deletion was confirmed by MLPA and the direct sequence of the junction fragment obtained from the genomic DNA by primer walking, which revealed the mutation spanning intron 15 and intron 17b, c.2908 þ 1085_3367 þ 260del7201. The deletion was previously reported from a French CF patient and his healthy mother, who came from South Korea. 9 The predicted CFTR protein lacks amino acids 970-1122, which correspond to the transmembrane regions 9, 10 and 11. A similar massive deletion spanning exon 16-17b: c.(?_2909)_(33367_?)del was found from a Japanese-Canadian patient with CF (Cystic Fibrosis Mutation Database), but the deletion breakpoint was different from the one in this study.
We also identified a novel splicing defect in the CFTR transcript from the other allele. The long PCR analysis of cDNA generated using the gene-specific primer on exon 24 revealed a deletion/skipping of exon 1 in the CFTR transcript without exons 16-17b deletion. As neither CF-causing mutations nor genomic rearrangements were detected in this allele, the deletion/skipping of exon 1 is most likely caused by a splicing defect. Although exon 2 was conserved in the transcript, the exact breakpoint remains undetermined. Five different splicing mutations in intron 1 have been reported to the Cystic Fibrosis Mutation Database, but they were not detected in the present study. Mouchel et al. 14 reported that the CFTR transcript lacking/ skipping exon 1 was present at low levels in the human fetal lung. Alternative 5 0 upstream exons of CFTR were directly spliced to exon 2, excluding exon 1 from the transcript. Such splicing variants have not been reported in CF patients. We detected a small amount of the splicing variant lacking exon 1 in nasal swab from a control subject. However, the transcript lacking exon 1 from the patient was not this type of splicing variant. Though the exact breakpoint was unknown, the skipping of exon 1 would cause translation to start downstream, most likely utilizing an ATG in exon 4 of the CFTR transcript, which leads to the generation of the CFTR protein lacking the N-terminus.
CF is rare in Japan and only 80 cases have been counted since 1994 by the Research Committee of Intractable Pancreatic Diseases (data not published). The median survival time is about 18 years. Early diagnosis and treatment is important. The elevated sweat chloride because of CFTR dysfunction is the gold standard for CF diagnosis. The pilocarpine iontophoresis is the standard method to stimulate sweat-gland secretion in the forearm or back. However, it requires experienced personnel and a quality-controlled laboratory, 15 which is hardly expected in Japan. Accordingly, detection of disease-causing mutations of CFTR is often necessary for the definite diagnosis of CF in Japan. Yoshimura and Anzai have found CFTRdele16-17b mutation (the breakpoint was not examined) in three patients (all in homozygosis), although most of the other detected CFTR mutations 2   1  3  2  6 a  4  5  6 b  11  13  7  8 9  10  12  14a  14b  15  16  17a  17b 18 19  20 21 22 23 . These data may suggest that the CFTRdele16-17b mutation is unique to Asian CF. Thus, we need to explore the presence of heterozygous deletion of 16-17b in Japanese CF patients. A 'junction fragment' test for the CFTRdele16-17b mutation was established in the present study (Figures 2b and c) . This test requires only conventional PCR technique and can be included in the first-step analysis.
Even the extensive genomic analysis including the examination of intragenic rearrangements (by MLPA, and so on) was performed, 1-5% of CF alleles in Caucasians remains undetermined. 4 The presence of mutations in a substantial number of Japanese CF patients remains unsolved (Research Committee of Intractable Pancreatic Diseases, data not published). Mutations in the regulatory elements located in sites distant from the coding regions are probably present in many of these cases, but they cannot be identified by currently available techniques.
The analysis of nasal swab transcripts can provide molecular evidence for dysfunctional CFTR in these cases. In the present study, we successfully detected the CFTR transcript lacking exons 16, 17a and 17b, and the other CFTR transcript lacking exon 1 in the extract of nasal swab obtained from the patient. This method has been used to detect aberrantly spliced transcripts and reduced mRNA levels that were associated with various types of nonsense, frameshift, stop and splicing mutations. [16] [17] [18] [19] In fact, we detected the CFTR transcripts with or without exon 9 in samples from both the patient and healthy control (Figure 1 ). The probability of alternative splicing of exon 9 is related to the genotype of poly T and TG repeats in intron 8. 20 The analysis of transcripts is not routinely performed to detect the CFTR mutations in medical genetic laboratories, but a recent study identified a novel insertion between exons 10 and 11. 21 Another study of CF patients with only one mutation in the coding region of CFTR demonstrated a pathological reduction in the amount of RNA from the other allele in 5 of 11 patients. 22 The respiratory mucosa in nasal cavities and bronchial airways has a similar structure. CFTR immunoreactivity was found in the apical membrane of ciliated epithelial cells and serous glandular cells of human nasal turbinates. 23 Nasal epithelial cells can be non-invasively and repeatedly obtained using a swab. Recent progress on reversetranscriptase PCR allows amplification of mRNA starting with a low copy number. Deletion or insertion mutations as well as aberrant splicing of CFTR can be detected by the analysis of transcripts.
In conclusion, the analysis of CFTR transcripts from nasal swab was useful to detect a large heterozygous deletion of the CFTR gene and to identify a splicing defect in the transcript from the other allele in a Japanese CF patient. The CFTRdele16-17b mutation may be unique to Asian CF. Analysis of the CFTR transcripts from nasal swab is recommended, when conventional sequence analysis proves to be negative in Japanese CF.
